Morphosys Gets $114M to Fund Antibody Programs
By Cormac Sheridan
Wednesday, September 25, 2013
Morphosys AG raised €84 million (US$114 million) in a private placement, adding another hefty chunk of change to what is already a robust balance sheet.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.